Drug intelligence / Profile preview

huangtengsu

Development stage
Unknown
Lead developer
China Resources Kunming Shenghuo Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Huangtengsu is a traditional Chinese proprietary medicine derived from Fibraurea recisa (Chinese name “huangteng”), formulated mainly as tablets and soft capsules and standardized for palmatine-type isoquinoline alkaloids with broad-spectrum antibacterial and antiviral activity.[1][3][7][14] It is used clinically in China for “clearing heat and detoxification” and is indicated for gynecologic inflammatory diseases, bacillary dysentery, enteritis, respiratory and urinary tract infections, postoperative or surgical wound infections, and conjunctivitis.[1][3][5][7] Pharmacologic studies of Fibraurea recisa and its alkaloids report anti-inflammatory, anti-infective, antidiabetic, hepatoprotective, antioxidant, ischemia–reperfusion protective, and anticancer effects, likely mediated through inhibition of microbial growth and modulation of inflammatory and oxidative stress pathways, though a single defined molecular target has not been established.[1][14]

Other names
Huangtengsu TabletsHuangtengsu Soft CapsulesHuangtengsu RuanjiaonangYellow rattan soft capsuleGuangfa Huangtengsu Ruanjiaonang

Beyond the preview

Go deeper on huangtengsu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on huangtengsu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call